Cisplatin accord fachinfo
WebPemetrexed Accord in combination with cisplatin The recommended dose of Pemetrexed Accord is 500 mg/m2 of body surface area (BSA) administered as an intravenous infusion over 10 minutes on the first day of each 21-day cycle. The recommended dose of cisplatin is 75 mg/m2 BSA infused over two hours approximately 30 minutes after completion WebApr 12, 2024 · Accord has cisplatin 1 mg/mL 50 mL and 100 mL vials on back order and the company cannot estimate a release date. Fresenius Kabi has cisplatin 1 mg/mL 50 …
Cisplatin accord fachinfo
Did you know?
WebCisplatin is only given by injection into a vein (an intravenous infusion). Supportive equipment should be available to control anaphylactic reactions. Cisplatin should not come into contact with any materials that contain aluminium. The recommended dosage of Cisplatin depends on your well-being, the WebFeb 1, 2003 · Cisplatină Accord se administrează numai prin injectare într-o venă (perfuzie intravenoasă). Echipamentul de asigurare a suportului trebuie să fie disponibil pentru a controla reacţiile anafilactice. Cisplatină Accord nu trebuie să vină în contact cu materiale care conţin aluminiu.
WebCisplatina Accord 1 mg / ml x 1 flacon x 10 ml concentrat pentru solutie perfuzbila - Catena. Cisplatina apartine unui grup de medicamente cunoscute sub numele de citostatice, care sunt utilizate în tratamentul cancerului. Cisplatina poate fi utilizată singură, dar si in asociere cu alte citostatice. ... Webexperienced nephrotoxicity as a result of cisplatin therapy. The carcinogenic potential of carboplatin has not been studied but compounds with similar mechanisms of action and …
WebCisplatin Accord 1 mg/ml Konzentrat zur Herstellung einer Infusionslösung. 2. QUALITATIVE UND QUANTITATIVE ZUSAMMENSETZUNG. 1 ml des Konzentrats zur Herstellung einer Infusionslösung enthält 1 mg Cisplatin. 10 ml des Konzentrats zur Herstellung einer Infusionslösung enthalten 10 mg Cisplatin. WebCisplatin Accord 1 mg/1 mL is available as a 10 mg/10 mL, 25 mg/25 mL, 50 mg/50 mL and 100 mg/100 mL solution for injection. For the full list of excipients, see . Section 6.1 List of Excipients. 3 PHARMACEUTICAL FORM . Solution for injection . Cisplatin Accord injection is a clear, colourless to pale yellow sterile solution of cisplatin 1 mg ...
WebOm indlægssedlen 1. Virkning og anvendelse 2. Det skal du vide, før du begynder at bruge Cisplatin Accord 3. Sådan skal du bruge Cisplatin Accord 4. Bivirkninger 5. Opbevaring 6. Pakningsstørrelser og yderligere oplysninger Indehaver af markedsføringstilladelsen og fremstiller Oplysninger tiltænkt læger og sundhedspersonale Revisionsdato
WebFind details around Cisplatin from Accord-Healthcare: the evolution of generics. shukr ada chordsWebJun 1, 2024 · A phase 2 trial of durvalumab in combination with gemcitabine and cisplatin demonstrated promising efficacy, with an objective response rate of 72% and a median overall survival of 20.2 months... theo\u0027s restaurant elkin ncWeb/de/drugs/4LKkeHTvGRdBw2MF4IGVmoSGOy6/fluorouracil-accord-50-mg-ml-injektions-infusionslosung-20-ml theo\\u0027s restaurant cambridge ohioWebCisplatin United States Pharmacopeia (USP) Reference Standard Synonym (s): cis-Diammineplatinum (II) dichloride, cis-Dichlorodiammine platinum (II), cis-Platinum (II) diammine dichloride, Cisplatin Linear Formula: Pt (NH3)2Cl2 CAS Number: 15663-27-1 Molecular Weight: 300.05 MDL number: MFCD00011623 PubChem Substance ID: … theo\u0027s rehoboth deWeb1. Mitä Cisplatin Accord 1 mg/ml on ja mihin sitä käytetään 2. Mitä sinun on tiedettävä, ennen kuin käytät Cisplatin Accord 1 mg/ml -valmistetta 3. Miten Cisplatin Accord 1 mg/ml -valmistetta käytetään 4. Mahdolliset haittavaikutukset 5. Cisplatin Accord 1 mg/ml -valmisteen säilyttäminen 6. Pakkauksen sisältö ja muuta tietoa 1. theo\\u0027s rehoboth dehttp://spc.nam.fi/indox/nam/html/nam/humpil/6/24363046.pdf theo\u0027s rehoboth beach deWebNov 30, 2024 · If cisplatin is used in combination chemotherapy, the dose of cisplatin must be reduced. A typical dose is 20 mg/m 2 or more once every 3 to 4 weeks unless in the combination therapy of small-cell and non-small-cell lung carcinoma, in which a typical dose of 80 mg/m 2 is administered. shukqueen painting by numbers